januvia pancreatic cancer risk

Future of Type 2 Diabetes Drugs Threatened

By on June 6, 2013 - Comments off

According to The New York Times, an animal study requested by Merck for its type 2 diabetes drug, Januvia, revealed worrisome changes in the pancreases of rats, leading to follow-up studies which now threaten the future of the lucrative diabetes drug, as well as all other drugs in its class.

Read the rest »